Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION

Last updated on 2018-12-12 History
Report ID 56007
Drug Identification Number 02457040
Brand name LABETALOL HYDROCHLORIDE INJECTION
Common or Proper name Labetalol Hydrochloride Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) LABETALOL HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 x 20mL vials
ATC code C07AG
ATC description BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-11-01
Actual start date
Estimated end date Unknown
Actual end date 2018-12-10
Shortage status Resolved
Updated date 2018-12-12
Company comments On allocation at 100%.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-12-12 French Compare
v6 2018-12-12 English Compare
v5 2018-11-02 English Compare
v4 2018-10-22 French Compare
v3 2018-10-22 English Compare
v2 2018-07-17 French Compare
v1 2018-07-17 English Compare

Showing 1 to 7 of 7